How much funding has Amptiv Biosciences raised?

Amptiv Biosciences has raised $300K in total funding, most recently a seed round.

Who are Amptiv Biosciences's investors?

Amptiv Biosciences's investors include Antler, BioTools Innovator, Atlas SGR.

When was Amptiv Biosciences founded?

Amptiv Biosciences was founded in 2024.

Where is Amptiv Biosciences headquartered?

Amptiv Biosciences is headquartered in United States.

What industry is Amptiv Biosciences in?

Amptiv Biosciences operates in Healthcare, Biotech.

How many employees does Amptiv Biosciences have?

Amptiv Biosciences has 1-10 employees.

Amptiv Biosciences

United States · Founded 2024 · $300K raised

Healthcare

Biotech

Employees: 1–10
Founded: 2024
Website: amptivbio.com

Total Funding: $300K
Last Round: $300K SeedDec 2024
Rounds: 1

About

Amptiv Biosciences is a biotechnology startup advancing mRNA therapeutics through proprietary post-transcriptional chemical modification technology. Built on a molecular toolkit invented at Stanford, Amptiv's chemistry enhances mRNA performance and stability to expand the therapeutic potential of mRNA-based medicines. Founded in 2023 and backed by Antler, the company develops modifications that augment the design and function of mRNA drugs.

Summary

Amptiv Biosciences is a Healthcare company based in United States, founded in 2024. It has raised $300K in total across 1 round, most recently a $300K Seed round in Dec 2024. Investors include Antler, BioTools Innovator and Atlas SGR.